Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BI 1015550 (Nerandomilast)
(D12975)		[1] Nerandomilast[1] Nerandomilast (D12975) 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 51 💬
2Galunisertib + Nerandomilast Combination
(D12975)		[2] Galunisertib,
Nerandomilast		[2] Galunisertib ,
Nerandomilast (D12975) 💬 		[2] PDE4B,
TGFBR1 💬 		[27] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Apelin signaling pathway, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Endocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, MAPK signaling pathway, Morphine addiction, Osteoclast differentiation, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, TGF-beta signaling pathway, Th17 cell differentiation, cAMP signaling pathway 💬[1] 2 💬
3Nerandomilast
(D12975)		[1] Nerandomilast[1] Nerandomilast (D12975) 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[3] 2, 51, 85 💬
4Nerandomilast formulation 1
(D12975)		[1] Nerandomilast[1] Nerandomilast (D12975) 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 51 💬
5Nerandomilast formulation 2
(D12975)		[1] Nerandomilast[1] Nerandomilast (D12975) 💬 [1] PDE4B 💬 [4] Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬[1] 51 💬